I discuss Trump's big health care changes: NIH study sections, the MMWR gag order, the US withdrawal from WHO, and more!Plenary Session tarafından oluşturuldu

The entire healthcare system is broken, it's not just health insurance companies.Plenary Session tarafından oluşturuldu

Is alcohol healthy for you? I break down everything you need to know about beer, wine, and spirits.Plenary Session tarafından oluşturuldu

Our 2 hour critical appraisal and ASH review. SO many guest starsPlenary Session tarafından oluşturuldu

Lecture on systematic review, given by Vinay Prasad MD MPH to students in the UCSF Training in Clinical Research Program, November 2024.Plenary Session tarafından oluşturuldu

Timothee Olivier and I discuss the top ESMO 2024 abstracts!Plenary Session tarafından oluşturuldu

AI in healthcare - my latest keynote addressPlenary Session tarafından oluşturuldu

"Masking Mistakes: Lessons from the Science, Policy, and Coverage of COVID-19", the 2024 Brian Shields Lecture on Institutional Ethics which took place on Monday, October 7, 2024 for the Emory Center for Ethics. A conversation with Carlos Del Rio, MD and Vinay Prasad, MD MPH with moderation by Gerard Vong, DPhil, Director of the MA in Bioethics pro…

Screening/ Drug efficacy/ Sotorasib/ Adaura and morePlenary Session tarafından oluşturuldu

My UCSF lecture on driver mutation lung cancerPlenary Session tarafından oluşturuldu

We break down the best studies from ASCOPlenary Session tarafından oluşturuldu

Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary SessionPlenary Session tarafından oluşturuldu

What you need to know in advance of ASCOPlenary Session tarafından oluşturuldu

Should trials have carbon footprint as an endpoint?Plenary Session tarafından oluşturuldu

My grand rounds; Beta blockers post MISingle center vs multicenter RCTMasksBoosters and morePlenary Session tarafından oluşturuldu

I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the yearPlenary Session tarafından oluşturuldu

Patient advocates, Pharma funding, and is MRD a suitable endpointPlenary Session tarafından oluşturuldu